ERp29 regulates response to doxorubicin by a PERK-mediated mechanism

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 6, 2011, Pages 1165-1171

  Farmaki, E ^a   Mkrtchian, S ^b   Papazian, I ^a   Papavassiliou, A G ^a   Kiaris, H ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adriamycin; Chemotherapy; ER stress; ERp29; PERK; UPR

Indexed keywords

CHAPERONE; DOXORUBICIN; EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE 3; PHOSPHOTRANSFERASE; PROTEIN ERP29; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DOXORUBICIN; DRUG RESISTANCE; EIF-2 KINASE; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MALE; MICE; MICE, KNOCKOUT; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA; POLYOMAVIRUS;

EID: 79955668408     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.03.003     Document Type: Article

References (31)

1. Mkrtchian S., Sandalova T. ERp29, an unusual redox-inactive member of the thioredoxin family. Antioxid. Redox Signal. 2006, 8:325-337.
2. Sargsyan E., Baryshev M., Backlund M., Sharipo A., Mkrtchian S. Genomic organization and promoter characterization of the gene encoding a putative endoplasmic reticulum chaperone, ERp29. Gene 2002, 285:127-139.
3. Sargsyan E., Baryshev M., Szekely L., Sharipo A., Mkrtchian S. Identification of ERp29, an endoplasmic reticulum lumenal protein, as a new member of the thyroglobulin folding complex. J. Biol. Chem. 2002, 277:17009-17015.
4. Cheretis C., Dietrich F., Chatzistamou I., Politi K., Angelidou E., Kiaris H., Mkrtchian S., Koutselini H. Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma. Am. J. Dermatopathol. 2006, 28:410-412.
5. Magnuson B., Rainey E.K., Benjamin T., Baryshev M., Mkrtchian S., Tsai B. ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol. Cell 2005, 20:289-300.
6. Mkrtchian S., Baryshev M., Sargsyan E., Chatzistamou I., Volakaki A.A., Chaviaras N., Pafiti A., Triantafyllou A., Kiaris H. ERp29, an endoplasmic reticulum secretion factor is involved in the growth of breast tumor xenografts. Mol. Carcinog. 2008, 47:886-892.
7. Malhotra J.D., Kaufman R.J. The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 2007, 18:716-731.
8. Sargsyan E., Baryshev M., Mkrtchian S. The physiological unfolded protein response in the thyroid epithelial cells. Biochem. Biophys. Res. Commun. 2004, 322:570-576.
9. Zhang B., Wang M., Yang Y., Wang Y., Pang X., Su Y., Wang J., Ai G., Zou Z. ERp29 is a radiation-responsive gene in IEC-6 cell. J Radiat Res (Tokyo) 2008, 49:587-596.
10. Lowe S.W., Bodis S., McClatchey A., Remington L., Ruley H.E., Fisher D.E., Housman D.E., Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 1994, 266:807-810.
11. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 2000, 6:1099-1108.
12. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
13. Brewer J.W., Diehl J.A. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl Acad. Sci. U.S.A. 2000, 97:12625-12630.
14. Lafkas D., Trimis G., Papavassiliou A.G., Kiaris H. P53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. Int. J. Cancer 2008, 123:967-971.
15. Baryshev M., Sargsyan E., Mkrtchian S. ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem. Biophys. Res. Commun. 2006, 340:617-624.
16. Koumenis C., Naczki C., Koritzinsky M., Rastani S., Diehl A., Sonenberg N., Koromilas A., Wouters B.G. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 2002, 22:7405-7416.
17. Rainey-Barger E.K., Mkrtchian S., Tsai B. The C-terminal domain of ERp29 mediates polyomavirus binding, unfolding, and infection. J. Virol. 2009, 83:1483-1491.
18. Dioufa N., Kassi E., Papavassiliou A.G., Kiaris H. Atypical induction of the unfolded protein response by mifepristone. Endocrine 2010, 38:167-173.
19. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000, 2:326-332.
20. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
21. Isaacs W.B., Carter B.S., Ewing C.M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 1991, 51:4716-4720.
22. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 1994, 4:1-7.
23. Su Q., Wang S., Gao H.Q., Kazemi S., Harding H.P., Ron D., Koromilas A.E. Modulation of the eukaryotic initiation factor 2 alpha-subunit kinase PERK by tyrosine phosphorylation. J. Biol. Chem. 2008, 283:469-475.
24. Park S., You K.H., Shong M., Goo T.W., Yun E.Y., Kang S.W., Kwon O.Y. Overexpression of ERp29 in the thyrocytes of FRTL-5 cells. Mol. Biol. Rep. 2005, 32:7-13.
25. Zhang D., Putti T.C. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp, Cell Res. 2010, 316:3522-3531.
26. Bourougaa K., Naski N., Boularan C., Mlynarczyk C., Candeias M.M., Marullo S., Fahraeus R. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol. Cell 2010, 38:78-88.
27. Virrey J.J., Dong D., Stiles C., Patterson J.B., Pen L., Ni M., Schonthal A.H., Chen T.C., Hofman F.M., Lee A.S. Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol. Cancer Res. 2008, 6:1268-1275.
28. Ranganathan A.C., Zhang L., Adam A.P., Aguirre-Ghiso J.A. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 2006, 66:1702-1711.
29. Lee A.S. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005, 35:373-381.
30. Morris J.A., Dorner A.J., Edwards C.A., Hendershot L.M., Kaufman R.J. Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J. Biol. Chem. 1997, 272:4327-4334.
31. Lee A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007, 67:3496-3499.